International Journal of STD & AIDS · 1991 · 30 citations · 8 references
PharmacyInfectious DiseasesPharmacologyAntimicrobial PharmacologyAntimicrobial PharmacotherapyInfectious Disease PharmacotherapySexually Transmitted Infection PharmacotherapyUrinary Tract Infection PharmacotherapyUrinary Tract InfectionsAntibiotic Therapy For ChlamydiaDoxycycline Treatment
Azithromycin is a novel azalide macrolide active against Chlamydia trachomatis and Ureaplasma urealyticum. High persistent tissue concentrations allow short courses or even single doses to be considered. Sixty-two patients were studied, 19 received azithromycin 1 g in a single dose, 22 received azithromycin 500 mg in a single dose on day 1 followed by 250 mg once daily for 2 days and 21 received doxycycline 200 mg in a loading dose followed by 100 mg every 12 h for 7 days. Efficacy of these 3 regimens was compared in the treatment of non-gonococcal urethritis (NGU). Clearance of C. trachomatis from post-treatment cultures was satisfactory with all regimens. Response defined as the absence of symptoms and reduction in polymorphonuclear leucocytes in a Gram stained smear of urethral secretion to less than 5 cells per hpf (x 100 objective) was statistically better for the 3 day regimen of azithromycin than for the other 2 regimens. All treatments were well tolerated. Three days or single doses of azithromycin compared to 7 days of tetracycline (or 10-14 days as is often prescribed) have obvious advantages for patient compliance.
8
Azithromycin in the treatment of sexually transmitted disease
Jón Ólafsson, Hjalti Thórarinsson, Raymond Ryan et al. · Journal of Antimicrobial Chemotherapy · 1990 · 129 citations
Medicine, Dermatology, Microbiology +11
L Slaney, Helen Chubb, Allan Ronald et al. · Journal of Antimicrobial Chemotherapy · 1990 · 76 citations
Recent Advances in Sexually Transmitted Diseases 2
Park Seon Young · Pathology · 1982 · 57 citations
O P Arya, HARRY MALLINSION, BASIL E. ANDREWS et al. · Sexually Transmitted Diseases · 1984 · 33 citations